rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Staffan Encrantz

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, Sight Sciences.

In numbers

Trades disclosed
55
Buys
30
Sells
1
Bought
$34.7M
Sold
$2.1M
Companies
1
Companies where not an officer
1
First trade
19 Jul 2021
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
SGHT Sight SciencesDirector, 10% owner · Medical Devices · last 10 Jun 202630 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
05Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$69K14,100 at $4.88filing
10 Jun 2026filed 11 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$69K14,100 at $4.88filing
4 Jun 2026filed 5 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—28,261 at $0.00filing
4 Jun 2026filed 5 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—28,261 at $0.00filing
16 Dec 2025filed 18 Dec 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$116K13,958 at $8.31filing
6 Jun 2025filed 6 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$118K27,900 at $4.22filing
5 Jun 2025filed 6 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$174K40,951 at $4.24filing
5 Jun 2025filed 6 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—30,952 at $0.00filing
4 Jun 2025filed 6 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$90K21,674 at $4.17filing
3 Jun 2025filed 3 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$100K25,230 at $3.97filing
2 Jun 2025filed 3 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$120K30,799 at $3.88filing
30 May 2025filed 3 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$157K42,753 at $3.67filing
29 May 2025filed 29 May 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$216K60,128 at $3.59filing
28 May 2025filed 29 May 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$94K26,715 at $3.52filing
27 May 2025filed 29 May 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$142K41,346 at $3.44filing
12 Mar 2025filed 13 Mar 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code J$673K243,000 at $2.77filing
11 Mar 2025filed 13 Mar 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code J$407K150,000 at $2.71filing
10 Mar 2025filed 13 Mar 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code J$304K120,000 at $2.53filing
21 Nov 2024filed 21 Nov 2024SGHT Sight SciencesMedical DevicesSEC FORM 4 Sold$2.1M551,802 at $3.73filing
21 Nov 2024filed 21 Nov 2024SGHT Sight SciencesMedical DevicesSEC FORM 4 Bought$2.1M551,802 at $3.73filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care31

Buys in green, sells in red, by the company’s sector.

Related people

Brenton TaylorEVP, Operations & R&D · EVP, Operations & R&D at Sight Sciences, filing Form 4 there in the last year
Alison BauerleinChief Operating Officer · Chief Operating Officer at Sight Sciences, filing Form 4 there in the last year
James RodbergChief Financial Officer · Chief Financial Officer at Sight Sciences, filing Form 4 there in the last year
Paul BadawiPresident and CEO · President and CEO at Sight Sciences, filing Form 4 there in the last year
David BadawiChief Technology Officer · Chief Technology Officer at Sight Sciences, filing Form 4 there in the last year